<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04334421</url>
  </required_header>
  <id_info>
    <org_study_id>57/2020</org_study_id>
    <nct_id>NCT04334421</nct_id>
  </id_info>
  <brief_title>APEMESH- Preventing Perineal Complications After Abdominoperineal Resection</brief_title>
  <official_title>APEMESH- Preventing Perineal Complications After Abdominoperineal Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Elisa Makarainen-Uhlback</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oulu</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Abdominoperineal resection leaves an empty space to be filled by mesh or musculocutaneus
      flap. Several studies have reported over 30% morbidity with perineal wound healing after
      abdominoperineal resection. Preoperative radiotherapy is a strong predictor for perineal
      complications. Musculocutaneus flaps and use of biological mesh seem to minimize perineal
      morbidity. The role of omentoplasty at APR is controversial.

      Previous studies on synthetic mesh repair on perineum are almost lacking.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this pilot study is to assess the feasibility and the potential benefits of
      synthetic mesh reconstruction in perineum in case-control setting.

      30 subjects will be prospectively enrolled to this study as intervention group. Controls
      matched with age, gender and preoperative radiotherapy are selected from retrospective data
      collected from Oulu University database and operated for rectal adenocarcinoma 2009-2017 with
      otherwise identical methods.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 3, 2020</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comprehensive Complication index</measure>
    <time_frame>30 days</time_frame>
    <description>Comprehensive Complication index is used to evaluate outcome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical site infection</measure>
    <time_frame>30 days</time_frame>
    <description>Surgical site infection classified by Clavien-Dindo score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reoperation rate</measure>
    <time_frame>30 days</time_frame>
    <description>Reoperations during primary stay at the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>30 days</time_frame>
    <description>Operative time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>30 days</time_frame>
    <description>Length of stay at the hospital during primary operation and recovery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs</measure>
    <time_frame>30 days</time_frame>
    <description>Costs by materials used</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total perineal healing time</measure>
    <time_frame>30 days</time_frame>
    <description>Time to point when perineum is closed and healed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perineal sinus</measure>
    <time_frame>30 days</time_frame>
    <description>Presence of perineal sinus at 30 days follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perineal hernia</measure>
    <time_frame>12 months</time_frame>
    <description>Perineal hernia by CT scan at 12 months follow-up</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Rectal Cancer</condition>
  <condition>Abdominoperineal Resection</condition>
  <condition>Wound Heal</condition>
  <arm_group>
    <arm_group_label>Mesh group</arm_group_label>
    <description>After resection, pelvic floor is reconstructed by synthetic composite mesh (Symbotex, Medtronic) and covered with subcutaneous flap.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Composite mesh</intervention_name>
    <description>Pelvic floor is reconstructed by synthetic composite mesh (Symbotex, Medtronic) to improve healing and prevent perineal herniation.</description>
    <arm_group_label>Mesh group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All study patients who have abdominoperineal resection
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Abdominoperineal resection and permanent colostoma

        Exclusion Criteria:

          -  Patient with a comorbid illness of condition that would preclude the use of surgery
             (ASA5)

          -  Potentially curable resection not possible

          -  Patient undergoing emergency procedure

          -  Metastatic disease

          -  Pregnant or suspected pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elisa Mäkäräinen-Uhlbäck, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oulu University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elisa Mäkäräinen-Uhlbäck, M.D.</last_name>
    <phone>+35883152282</phone>
    <email>elisa.makarainen-uhlback@ppshp.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tero Rautio, Ph.D.</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisa Mäkäräinen-Uhlbäck, M.D.</last_name>
      <email>elisa.makarainen-uhlback@ppshp.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 1, 2020</study_first_submitted>
  <study_first_submitted_qc>April 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 6, 2020</study_first_posted>
  <last_update_submitted>April 4, 2020</last_update_submitted>
  <last_update_submitted_qc>April 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Oulu</investigator_affiliation>
    <investigator_full_name>Elisa Makarainen-Uhlback</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

